Trityl candesartan
|
|
|
- CAS-Nr.
- 139481-72-4
- Englisch Name:
- Trityl candesartan
- Synonyma:
- Triphenyl Candesartan;TRITYL CANDESARTAN;N-tityl candesartan;Trityl Candesaratan;N-Trityl Candesartan;N-trimethylcandesartan;Trityl Candesartan (C9);Candesartan Impurity 8;CANDESARTAN INTERMEDIATE A;Trityl candesartan USP/EP/BP
- CBNumber:
- CB0763835
- Summenformel:
- C43H34N6O3
- Molgewicht:
- 682.77
- MOL-Datei:
- 139481-72-4.mol
|
Trityl candesartan Eigenschaften
- Schmelzpunkt:
- 163-165°C
- Siedepunkt:
- 908.6±75.0 °C(Predicted)
- Dichte
- 1.26±0.1 g/cm3(Predicted)
- storage temp.
- Sealed in dry,2-8°C
- Löslichkeit
- Chloroform (Slightly), Ethyl Acetate (Slightly), Methanol (Slightly, Heated)
- Aggregatzustand
- Solid
- pka
- 2.06±0.10(Predicted)
- Farbe
- White to Off-White
Sicherheit
- Risiko- und Sicherheitserklärung
- Gefahreninformationscode (GHS)
Trityl candesartan Chemische Eigenschaften,Einsatz,Produktion Methoden
Chemische Eigenschaften
Off-White Solid
Verwenden
Candesartan analog as angiotensin II antagonist.
Trityl candesartan Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Trityl candesartan Anbieter Lieferant Produzent Hersteller Vertrieb Händler.
Global( 232)Lieferanten
139481-72-4()Verwandte Suche:
- Candesartan N1-Trityl IMpurity
- 2-Ethoxy-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-c
- 2-Ethoxy-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-
- 2-ethoxy-1-[[(2'-(1-triphenylmethyl-1h-tetrazol-5-yl)biphenyl-4-yl)methyl]benzimidazole-7-carboxylic acid
- TRITYL CANDESARTAN
- (Trityl candesartan)2-Ethoxy-1-[[2-(2-Triphenyl Methyl)-2H-Tetrazole-5-YL](1,1-Biphenyl)-4-YL]Methyl]Benzimidazole-2-Carboxylic Acid
- 1H-Benzimidazole-7-carboxylic acid, 2-ethoxy-1-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-
- 2-Ethoxy-1-[[(2’-(1-triphenylmethyl-1H-tetrazol-5-yl)biphenyl-4-yl-)methyl]benzimidazole-7-carboxylicacid
- TRITYL CANDESARTAN ( FOR CANDESARTAN CILEXETIL )
- TritylCandesartan[CandesartabCilexetilIntermediates]
- TritylCandesartan,CandesartanCilexetil
- (1H)-Benzimidazole-7-carboxylicacid
- CANDESARTAN INTERMEDIATE A
- 2-Ethoxy-1-[[2-(2-Triphenylmethyl)-2H-Tetrazole-5-Yl](1,1-Biphenyl)-4-Yl]-Methyl]Benzimidazole-7-Carboylicacid
- 2-ethoxy-1-[[(2-(1-triphenylmethyl-1Htetrazol-5-yl)biphenyl-4-yl-)
- N-Trityl Candesartan
- Trityl candesartan/2-Ethoxy-1-[[(2'-(1-triphenylmethyl-1H-tetrazol-5-yl)biphenyl-4-yl)methyl]benzimidazole-7-carboxylic acid
- 2-Ethoxy-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)Methyl)-1H-benzo[d]iMidazole-7-carboxylic acid
- 1H-benzimidazole-7-carboxylic acid, 1-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-2-ethoxy
- 2-ethoxy-3-[[4-[2-[1-(triphenylmethyl)-5-tetrazolyl]phenyl]phenyl]methyl]-4-benzimidazolecarboxylic acid
- Candesartan Cilexetil Impurity 9
- 2-ETHOXY-1-[[(2-(1-TRIPHENYLMETHYL-1H-TETRAZOL-5-YL)BIPHENYL)METHYL] BENZIMIDAZOLE-7-CARBOXYLIC ACID
- Candesartan Impurity 8
- Candesartan Cilexetil Impurity 14
- Trityl Candesartan (C9)
- N-trimethylcandesartan
- Trityl candesartan USP/EP/BP
- 2-Ethoxy-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylic Acid
DISCONTINUED
- 2-Ethoxy-1-[[2?-[2-(Triphenylmethyl)-2H-Tetrazol-5-
Yl][1,1?-Biphenyl]-4-Yl]Methyl]-1H-Benzimidazole-7- Carboxylic Acid [N-Trityl Candesartan]
- Triphenyl Candesartan
- Candesartan Cilexetil
Intermediate 5
- N-tityl candesartan
- 2-Ethoxy-1-[[2'-(N-triphenylmethyltetrazol-5-yl)-biphenyl-4-yl]methyl]benzimidazole-7-carboxylic acid
- Trityl candesartan (Candesartan Cilexetil Impurity)
- Trityl Candesaratan
- 2-Ethoxy-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylic acid
- 139481-72-4
- C43H34N6O3
- Chiral Reagents
- Heterocycles
- Intermediates & Fine Chemicals
- Pharmaceuticals
- Intermediates of Candesartan
- Candesartan Cilexetil
- API intermediates
- INTERMEDIATESOF
- Intermediates
